Your browser doesn't support javascript.
loading
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Maher, Toby M; Corte, Tamera J; Fischer, Aryeh; Kreuter, Michael; Lederer, David J; Molina-Molina, Maria; Axmann, Judit; Kirchgaessler, Klaus-Uwe; Samara, Katerina; Gilberg, Frank; Cottin, Vincent.
Afiliación
  • Maher TM; Inflammation, Repair, and Development Section, National Heart and Lung Institute, Imperial College London, London, UK; National Institute for Health Research Respiratory Clinical Research Facility, Royal Brompton Hospital, London, UK. Electronic address: t.maher@rbht.nhs.uk.
  • Corte TJ; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Medical School, University of Sydney, Sydney, NSW, Australia.
  • Fischer A; University of Colorado School of Medicine, Denver, CO, USA; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Kreuter M; Center for Interstitial and Rare Lung Diseases, Department of Pulmonology and Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.
  • Lederer DJ; Divison of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, NY, USA; Regeneron Pharmaceuticals, New York, NY, USA.
  • Molina-Molina M; Respiratory Department, Unit of Interstitial Lung Diseases, University Hospital of Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain; Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Madrid, Spain.
  • Axmann J; F Hoffmann-La Roche, Basel, Switzerland.
  • Kirchgaessler KU; F Hoffmann-La Roche, Basel, Switzerland.
  • Samara K; F Hoffmann-La Roche, Athens, Greece.
  • Gilberg F; F Hoffmann-La Roche, Basel, Switzerland.
  • Cottin V; National Reference Coordinating Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Lyon, France; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Lancet Respir Med ; 8(2): 147-157, 2020 02.
Article en En | MEDLINE | ID: mdl-31578169
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_other_respiratory_diseases / 6_sense_organ_diseases Asunto principal: Fibrosis Pulmonar / Piridonas / Enfermedades Pulmonares Intersticiales Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Respir Med Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_other_respiratory_diseases / 6_sense_organ_diseases Asunto principal: Fibrosis Pulmonar / Piridonas / Enfermedades Pulmonares Intersticiales Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Respir Med Año: 2020 Tipo del documento: Article